In this interview, Stuart Rose, CEO of BioUk, offers a broader market view of the UK life sciences ecosystem, combining scientific, commercial, and sector leadership perspectives.

He argues that the UK continues to benefit from extraordinary underlying strengths: globally respected universities, high-quality scientific talent, a collaborative culture, and a proven ability to innovate under pressure.

He is equally candid, however, about the constraints facing smaller and emerging companies. The funding environment has been difficult, investor caution has increased, and many businesses need more practical support to secure investment and move forwards with confidence. Even so, his outlook remains strongly positive: the sector has depth, resilience, and long-term strategic importance, provided the right mechanisms are in place to keep capital and capability flowing into early-stage innovation.

Richard Williams, founder and CEO of Healome Therapeutics, discusses what it takes to turn deep scientific research into a business with real-world clinical potential.

Drawing on his experience, he explains the long path from science to product, and the strategic, manufacturing, and regulatory decisions that have to be made well before a company is fully established.

A central theme of the conversation is the need for more specialist support around early-stage life sciences growth. Richard highlights the difficulty of finding investors who truly understand deep tech and biotech timelines, as well as the practical challenge of securing small-scale manufacturing capacity for early trials. He also points to the strengths of the UK ecosystem, especially clustering, communication, and focused public support, while stressing the need to retain more capability, talent, and capital within the UK as businesses scale.

Steve Rowbotham, founder and CEO of Navigator, brings a founder’s perspective to the UK growth story, shaped by his own journey from elite sport into entrepreneurship.

He talks about performance culture, ambition, and the mindset required to build a business in a fast-moving market. His view of the UK is positive: there is real entrepreneurial energy here, alongside a strong sense of community among founders and operators.

But the conversation also surfaces some of the tensions founders face in practice. Steve discusses the difficulty of raising capital at certain stages, the challenge of fitting into rigid investment ‘boxes’, intense competition for talent, and the need to stay agile as AI develops. He also touches on the role of privacy and regulation, arguing that businesses which build with future requirements in mind are better placed to create lasting value.

In this conversation, Russ Shaw CBE, founder of Tech London Advocates and Global Tech Advocates, reflects on the evolution of the UK tech ecosystem, from its earlier growth phases through to its current position on the global stage.

He makes the case that one of the UK’s defining strengths has been its culture of collaboration – leaders, founders, investors, and advocates coming together around a shared ambition to help the sector grow. He also highlights the practical measures that have helped the market mature, from policy interventions to the UK’s wider reputation for rule of law and innovation.

At the same time, the discussion is clear-eyed about what still needs attention. Russ points to the continuing challenge of scaling capital, the importance of attracting and retaining global talent, and the need for the UK to keep moving with pace in areas such as AI and advanced technologies. His central message is an optimistic but disciplined one: the UK has built something strong, but it cannot afford complacency.